Search research articles
Contact Us
Filters
Showing results (1-10 of 104) with videos related to
Page
of 11
Sort By:
Neoplasia (New York, N.Y.)
|
October 3, 2021
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape
Sebastian Schwind, Madlen Jentzsch, Anne Sophie Kubasch, et al.
Cancers
|
October 27, 2019
Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia
Madlen Jentzsch, Sebastian Schwind, Enrica Bach, et al.
Current Treatment Options in Oncology
|
February 1, 2020
Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy
Sebastian Schwind, Madlen Jentzsch, Enrica Bach, et al.
Cancers
|
October 28, 2023
MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance
Paula Reichelt, Stephan Bernhart, Franziska Wilke, et al.
Endoscopy
|
March 23, 2017
Giant duodenal hematoma after duodenal biopsy in a patient with suspected acute gastrointestinal graft-versus-host disease
Robert Henker, Sebastian Schwind, Christine Döhring, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
March 9, 2019
[Meningococcal sepsis without cerebrospinal fluid abnormalities under treatment with eculizumab]
Madlen Jentzsch, Sebastian Schwind, Vladan Vucinic, et al.
Hemasphere
|
February 22, 2021
Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation
Dominic Brauer, Donata Backhaus, Rosmarie Pointner, et al.
Hemasphere
|
February 20, 2020
Outcomes of Older Patients with <i>NPM1</i> Mutated and <i>FLT3</i>-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation
Madlen Jentzsch, Juliane Grimm, Marius Bill, et al.
Blood Advances
|
August 19, 2020
Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation
Juliane Grimm, Madlen Jentzsch, Marius Bill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 1, 2019
Pretreatment CD34<sup>+</sup>/CD38<sup>-</sup> Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation
Madlen Jentzsch, Ulrike Geus, Juliane Grimm, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 104) with videos related to
Sort By:
Page
of 11
Neoplasia (New York, N.Y.)
|
October 3, 2021
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape
Sebastian Schwind, Madlen Jentzsch, Anne Sophie Kubasch, et al.
Cancers
|
October 27, 2019
Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia
Madlen Jentzsch, Sebastian Schwind, Enrica Bach, et al.
Current Treatment Options in Oncology
|
February 1, 2020
Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy
Sebastian Schwind, Madlen Jentzsch, Enrica Bach, et al.
Cancers
|
October 28, 2023
MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance
Paula Reichelt, Stephan Bernhart, Franziska Wilke, et al.
Endoscopy
|
March 23, 2017
Giant duodenal hematoma after duodenal biopsy in a patient with suspected acute gastrointestinal graft-versus-host disease
Robert Henker, Sebastian Schwind, Christine Döhring, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
March 9, 2019
[Meningococcal sepsis without cerebrospinal fluid abnormalities under treatment with eculizumab]
Madlen Jentzsch, Sebastian Schwind, Vladan Vucinic, et al.
Hemasphere
|
February 22, 2021
Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation
Dominic Brauer, Donata Backhaus, Rosmarie Pointner, et al.
Hemasphere
|
February 20, 2020
Outcomes of Older Patients with <i>NPM1</i> Mutated and <i>FLT3</i>-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation
Madlen Jentzsch, Juliane Grimm, Marius Bill, et al.
Blood Advances
|
August 19, 2020
Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation
Juliane Grimm, Madlen Jentzsch, Marius Bill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 1, 2019
Pretreatment CD34<sup>+</sup>/CD38<sup>-</sup> Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation
Madlen Jentzsch, Ulrike Geus, Juliane Grimm, et al.
Page
of 11